These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 31752551

  • 21. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A.
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [Abstract] [Full Text] [Related]

  • 22. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Gordon PC, Cohen DJ, Kleiman NS, Montgomery JA, Semder CA, Kennedy KF, Keyes MJ, Piana RN, EVENT Investigators.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):E356-64. PubMed ID: 22511502
    [Abstract] [Full Text] [Related]

  • 23. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun 01; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 24. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.
    Mangione FM, Biering-Sørensen T, Nochioka K, Jatene T, Silvestre OM, Hansen KW, Sørensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S.
    Catheter Cardiovasc Interv; 2018 Apr 01; 91(5):867-873. PubMed ID: 28722266
    [Abstract] [Full Text] [Related]

  • 25. Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent.
    Maillard L, Tavildari A, Barra N, Billé J, Joly P, Peycher P, Silvestri M, Vochelet F.
    Arch Cardiovasc Dis; 2017 Dec 01; 110(12):682-688. PubMed ID: 29102364
    [Abstract] [Full Text] [Related]

  • 26. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S, Panchal HB, Bagai J, Banerjee S, Brilakis ES, Mukherjee D, Kumar G, Shanmugasundaram M, Paul TK.
    Cardiovasc Revasc Med; 2019 Sep 01; 20(9):758-767. PubMed ID: 30503811
    [Abstract] [Full Text] [Related]

  • 27. Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Neupane S, Khawaja O, Edla S, Singh H, Othman H, Bossone E, Yamasaki H, Rosman HS, Eggebrecht H, Mehta RH.
    Catheter Cardiovasc Interv; 2019 Jul 01; 94(1):98-104. PubMed ID: 30585391
    [Abstract] [Full Text] [Related]

  • 28. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000-2005).
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):41-9. PubMed ID: 20310019
    [Abstract] [Full Text] [Related]

  • 29. Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry.
    Negreira-Caamaño M, Abellán-Huerta J, Lozano-Ruiz-Poveda F, Sánchez-Pérez I, López-Lluva MT, Pérez-Díaz P, López JG, Jurado-Román A.
    Angiology; 2021 Nov 01; 72(10):979-985. PubMed ID: 33966474
    [Abstract] [Full Text] [Related]

  • 30. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.
    Arch Cardiovasc Dis; 2013 Nov 01; 106(11):554-61. PubMed ID: 24231052
    [Abstract] [Full Text] [Related]

  • 31. Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry.
    Wlodarczak A, Lanocha M, Jastrzebski A, Pecherzewski M, Szudrowicz M, Jastrzebski W, Nawrot J, Lesiak M.
    Catheter Cardiovasc Interv; 2019 Apr 01; 93(5):E287-E292. PubMed ID: 30537203
    [Abstract] [Full Text] [Related]

  • 32. Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.
    Gaede L, Liebetrau C, Dörr O, Blumenstein J, Elsässer A, Hamm CW, Möllmann H, Schlundt C, Nef HM, Achenbach S.
    Coron Artery Dis; 2017 Nov 01; 28(7):588-596. PubMed ID: 28704242
    [Abstract] [Full Text] [Related]

  • 33. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF, EVENT Investigators.
    Catheter Cardiovasc Interv; 2012 Dec 01; 80(7):1127-36. PubMed ID: 22431166
    [Abstract] [Full Text] [Related]

  • 34. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2013 Aug 01; 6(8):777-89. PubMed ID: 23968698
    [Abstract] [Full Text] [Related]

  • 35. Feasibility and clinical outcome of rotational atherectomy in patients presenting with an acute coronary syndrome.
    Allali A, Abdelghani M, Mankerious N, Abdel-Wahab M, Richardt G, Toelg R.
    Catheter Cardiovasc Interv; 2019 Feb 15; 93(3):382-389. PubMed ID: 30196568
    [Abstract] [Full Text] [Related]

  • 36. Outcomes of different revascularization strategies among patients presenting with acute coronary syndromes without ST elevation.
    Ram E, Sternik L, Klempfner R, Iakobishvili Z, Peled Y, Shlomo N, Raanani E.
    J Thorac Cardiovasc Surg; 2020 Oct 15; 160(4):926-935.e6. PubMed ID: 31653430
    [Abstract] [Full Text] [Related]

  • 37. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A, Balasubramaniam K, Alhous MHA, Lee K, Jesudason P, Rashid M, Mamas MA, Zaman AG.
    Catheter Cardiovasc Interv; 2017 Jun 01; 89(7):1195-1204. PubMed ID: 28029209
    [Abstract] [Full Text] [Related]

  • 38. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G, Baber U, Stefanini GG, Aquino M, Stone GW, Sartori S, Steg PG, Wijns W, Smits PC, Jeger RV, Leon MB, Windecker S, Serruys PW, Morice MC, Camenzind E, Weisz G, Kandzari D, Dangas GD, Mastoris I, Von Birgelen C, Galatius S, Kimura T, Mikhail G, Itchhaporia D, Mehta L, Ortega R, Kim HS, Valgimigli M, Kastrati A, Chieffo A, Mehran R.
    Am J Cardiol; 2015 Sep 15; 116(6):845-52. PubMed ID: 26174605
    [Abstract] [Full Text] [Related]

  • 39. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ, Nogic J, Montone RA, Cameron JD, Nerlekar N, Brown AJ.
    Cardiovasc Revasc Med; 2018 Sep 15; 19(7 Pt B):837-844. PubMed ID: 29685385
    [Abstract] [Full Text] [Related]

  • 40. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD, Wragg A.
    Catheter Cardiovasc Interv; 2013 May 15; 81(6):E237-44. PubMed ID: 22707383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.